tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Max Estates and New York Life Boost Funding in Noida Subsidiary via Additional CCD Issue

Story Highlights
  • Max Estates and New York Life have injected fresh capital into Max Estates Noida Private Limited.
  • Both investors subscribed to additional compulsory convertible debentures, reinforcing funding for the Noida subsidiary’s projects.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Max Estates and New York Life Boost Funding in Noida Subsidiary via Additional CCD Issue

Claim 70% Off TipRanks Premium

Max Estates Limited ( (IN:MAXESTATES) ) has provided an update.

Max Estates Limited and New York Life Insurance Company have increased their investment in subsidiary Max Estates Noida Private Limited through a further subscription of unsecured compulsory convertible debentures, deepening the capital base of the Noida-focused entity. On 9 January 2026, New York Life subscribed to debentures worth INR 66 crore and Max Estates subscribed to debentures worth INR 68.1 crore, following an earlier, larger CCD subscription, strengthening funding for the subsidiary’s projects and underscoring the strategic partnership between the two investors.

More about Max Estates Limited

Max Estates Limited is a listed real estate development company in India, engaged in developing and operating commercial and residential properties, with a focus on projects in the Delhi-NCR region, including Noida and New Delhi, where it operates through subsidiaries such as Max Estates Noida Private Limited.

Average Trading Volume: 13,336

Technical Sentiment Signal: Sell

Current Market Cap: 71.54B INR

For a thorough assessment of MAXESTATES stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1